Bio Rad Laboratories Inc (NYSE:BIO) over-valued by 13%
| Website | http://www.bio-rad.com/ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $18,814,611,456 |
| Beta | 0.807501 |
| Average Volume | $189,707 |
| Last Dividend | 0% |
| Price on Feb 16, 2021 | $630.13 |
| Autochartist™ Valuation | $546.27 |
| Conclusion |
13% over-valued |
| Download Report |
